BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24568510)

  • 21. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
    Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
    Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
    Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
    Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.
    Chen J; Wen J; Zheng Y; Yang H; Luo K; Liu Q; Hu R; Tan Z; Huang Q; Fu J
    Tumour Biol; 2015 Sep; 36(9):6797-803. PubMed ID: 25835977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
    Jin Z; Zhao Z; Cheng Y; Dong M; Zhang X; Wang L; Fan X; Feng X; Mori Y; Meltzer SJ
    Cancer; 2013 Oct; 119(20):3604-9. PubMed ID: 23893879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
    Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
    Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma.
    Shi ZZ; Shang L; Jiang YY; Shi F; Xu X; Wang MR; Hao JJ
    Cancer Biomark; 2015; 15(6):755-61. PubMed ID: 26406417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
    Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
    Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
    Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
    Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
    Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
    Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.